Recruiting

Genetic Variants

Sponsor:

University Health Network, Toronto

Code:

NCT00145964

Conditions

Liver Cirrhosis, Biliary

Biliary Cirrhosis, Primary

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Primary biliary cirrhosis (PBC) is a disease of the liver, which predominantly affects women. It causes slowly progressive liver disease, which eventually causes liver failure, requiring a liver transplant. Several different studies of large patient cohorts indicate that the cause of this disease is likely due to a combination of factors including genetic and environmental. PBC is associated with several other "autoimmune diseases" - recently a gene has been identified to be abnormal in individuals with another autoimmune liver disease, namely rheumatoid arthritis. This gene usually tells the body when to switch off an immune response. This study plans to identify whether individuals diagnosed with PBC have a similar abnormality in this gene called protein Tyrosine Phosphatase.

Conditions

Liver Cirrhosis, Biliary

Biliary Cirrhosis, Primary

Study ID

NCT00145964

Start date

Aug, 2004

Status verified date

Aug, 2005

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • patients attending Liver Clinic at Toronto Western Hospital, Toronto, ON, Canada
  • AMA positive and liver biopsy proven PBC.

Exclusion Criteria:

- AMA negative PBC

Study Design

Enrollment

500 participants

Interventions and Outcome Measures

Central Contacts and Locations

Central contacts

Catalina Coltescu

416-603-5832

Locations

Liver Clinic, Toronto Western Hospital, UHN.

Recruiting

Toronto, Ontario, Canada, M5T 2S8

Contacts

Jenny (E.J.L.) Heathcote, MD

416-603-5914

Principal Investigator:

E. J. L. Heathcote, M.D.

More Information

Sponsor

University Health Network, Toronto

Last update posted

Nov 29, 2005

Last verified

Aug, 2005

Keywords

  • Biliary Cirrhosis, Primary
  • genes
  • autoimmune disease

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University Health Network, Toronto on 2005-11-29.